Recurrent hypersomnia
ICD-10 G47.13 is a billable code used to indicate a diagnosis of recurrent hypersomnia.
Recurrent hypersomnia is characterized by excessive daytime sleepiness and prolonged sleep episodes that occur repeatedly over time. Patients may experience episodes of excessive sleep lasting from several days to weeks, often following a period of normal sleep patterns. This condition can significantly impact daily functioning, leading to difficulties in work, social interactions, and overall quality of life. The etiology of recurrent hypersomnia can be multifactorial, including genetic predispositions, environmental factors, and underlying medical conditions. It is essential to differentiate recurrent hypersomnia from other sleep disorders such as narcolepsy, sleep apnea, and idiopathic hypersomnia, as the management and treatment strategies may differ. Diagnosis typically involves a thorough clinical evaluation, sleep history, and may include polysomnography or multiple sleep latency tests to assess sleep architecture and daytime sleepiness. Treatment options may include lifestyle modifications, stimulant medications, and addressing any underlying conditions contributing to the hypersomnia.
Detailed sleep history, results from polysomnography, and clinical assessments.
Patients presenting with excessive daytime sleepiness, prolonged sleep episodes, and difficulty functioning.
Ensure clear documentation of recurrent episodes and any comorbid conditions.
Neurological evaluations, history of sleep patterns, and any neurological assessments.
Patients with neurological conditions presenting with hypersomnia symptoms.
Document any neurological findings that may contribute to hypersomnia.
Used to evaluate sleep architecture in patients with recurrent hypersomnia.
Document the indication for the sleep study and results.
Sleep specialists should ensure comprehensive reporting of findings.
Common symptoms include excessive daytime sleepiness, prolonged sleep episodes, and difficulty waking up after sleep. Patients may also experience cognitive impairments and mood disturbances.
